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Abstract
Trypanosoma cruzi, the etiological agent of Chagas’ disease, affects 8 million people pre-
dominantly living in socioeconomic underdeveloped areas. T. cruzi trypomastigotes (Ty),
the classical infective stage, interact with the extracellular matrix (ECM), an obligatory step
before invasion of almost all mammalian cells in different tissues. Here we have character-
ized the proteome and phosphoproteome of T. cruzi trypomastigotes upon interaction with
ECM (MTy) and the data are available via ProteomeXchange with identifier PXD010970.
Proteins involved with metabolic processes (such as the glycolytic pathway), kinases, flagel-
lum and microtubule related proteins, transport-associated proteins and RNA/DNA binding
elements are highly represented in the pool of proteins modified by phosphorylation. Fur-
ther, important metabolic switches triggered by this interaction with ECM were indicated by
decreases in the phosphorylation of hexokinase, phosphofructokinase, fructose-2,6-bispho-
sphatase, phosphoglucomutase, phosphoglycerate kinase in MTy. Concomitantly, a
decrease in the pyruvate and lactate and an increase of glucose and succinate contents
were detected by GC-MS. These observations led us to focus on the changes in the glyco-
lytic pathway upon binding of the parasite to the ECM. Inhibition of hexokinase, pyruvate
kinase and lactate dehydrogenase activities in MTy were observed and this correlated with
the phosphorylation levels of the respective enzymes. Putative kinases involved in protein
phosphorylation altered upon parasite incubation with ECM were suggested by in silico anal-
ysis. Taken together, our results show that in addition to cytoskeletal changes and protease
activation, a reprogramming of the trypomastigote metabolism is triggered by the interaction
of the parasite with the ECM prior to cell invasion and differentiation into amastigotes, the
multiplicative intracellular stage of T. cruzi in the vertebrate host.
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Author summary
Adhesion of Trypanosoma cruzi to distinct elements of ECM involving different surface
proteins from the infective stage of the parasite has been described. Despite the relevance
of ECM for T. cruzi infection, the signaling pathways triggered in trypomastigotes upon
interactions with ECM are less well understood. In previous work we demonstrated the
dephosphorylation of proteins, such as α-tubulin, paraflagellar rod proteins and ERK 1/2
in trypomastigotes incubated with either laminin or fibronectin. Further, we described
changes in the S-nitrosylation and nitration pattern of proteins from trypomastigote incu-
bated with ECM. To expand our knowledge on ECM triggered parasite signaling we
applied quantitative proteomic and phosphoproteomic studies to trypomastigotes incu-
bated with ECM (MTy) compared to controls (Ty). Our results indicate relevant changes
in total protein and phosphoprotein profiles in MTy. The kinases implicated in the modi-
fications were suggested by bioinformatic analyses, as well as the number of modifications
and the frequency of amino acids per peptide that have been modified. Proteins involved
in metabolic processes, including enzymes from the glycolytic pathway, phosphatases and
kinases were the most representative groups among the proteins modified by phosphory-
lation. Quantification of metabolites in MTy and Ty also indicated that glucose metabo-
lism is impaired in trypomastigotes incubated with ECM. The significant inhibition of
hexokinase, pyruvate kinase and lactate dehydrogenase activities in MTy associated with
phosphorylation levels, strongly suggests that trypomastigotes reprogram their metabo-
lism in response to interaction with the extracellular matrix, an obligatory step prior to
host cell invasion.
Introduction
The protozoan T. cruzi, the etiological agent of Chagas’ disease, affects a wide range of mam-
malian hosts, including humans. It is estimated that 8 million people are infected and 25 mil-
lion are at risk, most of them living in areas of poor socioeconomic development [1]. The cell
cycle of T. cruzi involves an invertebrate vector (triatomine bugs) and a mammalian host, and
well-defined developmental stages (epimastigotes, metacyclic trypomastigotes, amastigotes
and blood trypomastigotes). T. cruzi trypomastigotes, the classical infective stage, invade
almost all mammalian cell and tissue types, and invasion is an obligatory step in their life-cycle
in mammals. An essential step immediately prior to the mammalian cell invasion is the inter-
action of the parasite with the surrounding extracellular matrix.
The extracellular matrix (ECM) is a highly dynamic non-cellular three-dimensional macro-
molecular network, which regulates different cellular functions, such as growth, differentiation
or survival [cf. 2]. Its composition includes structural components (“matrisome”, [3]) and ele-
ments that can interact with or remodel the ECM [4]. Collagens, proteoglycans and glycopro-
teins (laminins, fibronectins, thrombospondins, tenascins, among others) constitute the main
core of the ECM proteins. ECM-affiliated proteins (such as mucins, syndecans, plexins) and
ECM-regulators (such as lysyl oxidases, sulfatases, extracellular kinases, proteases and secreted
factors, such as TGFβ, cytokines) were classified as matrisome-associated proteins [4]. Cell-
ECM interactions occur mainly by integrins present at the cell surface, which connect the
extracellular signals and the intracellular response by the activation of specific signaling path-
ways [5, 6] and dysregulation of the ECM is associated with the development of several patho-
logical conditions [4,7].
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Adhesion of Trypanosoma cruzi and other parasites to distinct elements of ECM has been
described to involve different surface proteins from the infective stage of the parasite, of which
the gp85/transialidase family plays an essential role (rev. [8]). T. cruzi binds to collagen [9],
fibronectin [10–14], laminin [11,15, 16, 17], thrombospondin [11], [18], heparan sulfate [11,
12, 14, 19], galectin-3 [20, 21], as well as TGF-β [22]. Also, remodeling of ECM was observed
during infection, with modifications in collagen and fibronectin content, as well as reorganiza-
tion of laminin [13], at least partially due to T. cruzi proteolytic enzymes [23–25].
Despite the relevance of ECM for T. cruzi infection, the signaling pathways triggered by the
trypomastigote-ECM interaction are less well known. Recently, we demonstrated a decrease in
S-nitrosylation and nitration in the majority of the trypomastigote proteins when parasites are
incubated with ECM [26]. In addition, dephosphorylation of proteins, such as α-tubulin, par-
aflagellar rod proteins (PFR or PAR), as well as ERK 1/2 was observed in trypomastigotes incu-
bated with either laminin or fibronectin [27], although these do not reflect the entirety of
possible interactions between parasite and ECM. To have a better understanding of the pro-
cess, quantitative proteomic and phosphoproteomic approaches were employed to analyze
changes in T. cruzi trypomastigote proteins when the parasites are incubated with ECM.
Herein we show important changes in the T. cruzi trypomastigotes proteome, as well as in pro-
tein phosphorylation levels upon interaction with ECM. Proteins involved with metabolic pro-
cesses, phosphatases, kinases and RNA/DNA binding elements were highly represented
among the proteins modified by phosphorylation. In particular, a decrease of the glycolytic
pathway was suggested by metabolite quantification and measurement of hexokinase, pyruvate
kinase and lactate dehydrogenase activities, suggesting an extensive metabolic adaptation of
trypomastigotes prior to host cell invasion. Taken together, our data show that not only struc-
tural adaptations but also important metabolic changes occur upon parasite interaction with
ECM. Understanding these changes may further elucidate the adaptive mechanisms involved
in parasite-host interaction.
Materials and methods
Trypanosoma cruzi culture and incubation with ECM (Geltrex)
Parasite culture. T. cruzi trypomastigotes, Y strain, were obtained as described [28]. Five
days after epithelial cultured cells (LLCMK2) infection, trypomastigotes released into the cul-
ture medium were collected and spun down at 5,000 x g for 10 min. The pellet was resus-
pended in cold PSG buffer (5 mM NaH2PO4/Na2HPO4 pH 8.0, 7.3 mM NaCl, 1% dextrose)
and the trypomastigotes were purified by DEAE-cellulose as described [29]. Briefly, DEAE-cel-
lulose column was washed twice with PS buffer (5 mM NaH2PO4/Na2HPO4 pH 8.0, 7.3 mM
NaCl), followed by three washes with PSG buffer. Parasites were then added to the column,
washed with PSG and the purified parasites recovered in the flow through.
ECM-treated trypomastigotes (MTy). Purified trypomastigotes (5 x 108 parasites) were
resuspended in 5 mL of Modified Eagle’s Medium (MEM) supplemented with 2% FBS, mixed
with 150 μL Geltrex (Geltrex™ LDEV-Free Reduced Growth Factor Basement Membrane
Matrix, Invitrogen) in 15 mL tubes, and incubated for 2 h at 37˚C and 5% CO2. After incuba-
tion with ECM, trypomastigotes were spun down (4,000 x g for 5 min), the pellet ressuspended
in 5 mg/mL collagenase, 10 mM HEPES pH 7.4, 0.36 mM CaCl2 and incubated for 15 min at
37˚C and 5% CO2. After three washes with PBS containing 10 mM EDTA (PBS-EDTA), the
parasites were finally washed with PBS-EDTA supplemented with protease and phosphatase
inhibitors (0.1 mM NaF, 0.1 mM Na3VO4, 0.05 mM sodium β-glicerophosphate; SIGMA-
FAST™ Protease Inhibitor Tablets-SIGMA-ALDRICH; 0.1 mM PMSF), frozen and kept at
-80˚C.
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Proteome and phosphoproteome strategy
Protein extraction and digestion. Frozen pellets of trypomastigotes were resuspended in
200 μL of Lysis Buffer (4% SDS, 25 mM TCEP, 50 mM N-Ethyl Maleimide, 0.01 M NaPO4 pH
6.0, 0.1 M NaCl, containing phosphatase and protease inhibitors, as described above). Lysates
were sonicated for 15 min (frequency of 30%) and heated to 65˚C for 10 min. Lysates were
then treated as follows: 100 μL of lysate was treated with 400 μL methanol, 100 μL chloroform
and 300 μL milliQ water, with 1 min of strong agitation between the additions. The samples
were spun down at 9000 x g for 5 min at room temperature, the upper phase carefully
removed, 300 μL methanol were added to the pellet and centrifuged as above. The entire
supernatant was removed and the pellet was air dried at room temperature. The pellet was
resuspended in 200 μL 8 M Urea, 0.1 M Tris-HCl pH 8.0, 1 mM CaCl2 and the total protein
quantified. The material was digested overnight at 37˚C with LysC (Pierce™ Lys-C Protease,
MS Grade) at 1:100 ratio (protease: total protein), diluted 8-fold in 1 M Urea, 0.1 M Tris-HCl
pH 8.0, 1 mM CaCl2, and treated with trypsin (Pierce™ Trypsin Protease, MS Grade) at 1:100
ratio (protease:total protein), for 4 h at 37˚C. After the incubation, TFA was added to 1% final
concentration and the peptides desalted by Sep-Pak columns (Sep-Pak C18 3 cc Vac Cartridge,
WATERS), as manufacturer recommendations. The material was air dried by speedvac, resus-
pended in 50 mM HEPES (pH 8.5) and the peptides quantified by CBQCA (CBQCA Protein
Quantitation Kit–Molecular probes/Invitrogen) prior to Tandem Mass Tag labeling. Three
independent biological samples from parasites incubated or not with ECM were analyzed.
TMT-Sixplex incorporation and HILIC fractionation. After protein digestion, peptide
labeling was done following the procedures for Tandem Mass Tags labeling (TMTsixplex™
Label Reagent, Thermo Fisher Scientific). TMT-tags (0.8 mg/tag) were diluted in 41 μL of
anhydrous acetonitrile (ACN) and mixed for 5 min at room temperature. Each tag was
carefully transferred to the peptide samples from trypomastigotes incubated with ECM
(MTy = TMT-129, 130, 131) and incubated without ECM (control Ty–TMT-126, 127 and
128).
The peptide-TMT mixtures were incubated for 120 min at room temperature. After incuba-
tion, 8 μL of 5% hydroxylamine was added and incubated for 15 min to quench the labelling
reaction. Samples were then mixed together in one tube, in a quantity of 270 μg peptide-TMT/
sample, a total of 1620 μg. The mixture was then filtered on a Sep-Pak C18, cartridge to remove
free tags and then dried in Speedvac. The sample was then resuspended in 200 μL 80% ACN,
0.1% TFA. TMT labeled peptides were injected onto a TSKgel Amide-80 column (4.6mm x
25cm, 3um particle size) and guard column (TSKgel Amide-80, 4.6 x 1.0cm, 3um particle
size), using a Dionex Ultimate 3000 HPLC system. Buffer A was 0.1% TFA in water and buffer
B was 0.1% TFA in 100% acetonitrile. Chromatography was performed at 0.6 mL/min at 30˚C,
starting at 80% buffer B, reducing to 70% B after 10 min and then to 60%B after a further 30
min and finally to 0% B after a further 5 min (held for 10 min). Buffer B was then increased to
80%B for 35 min for re-equilibration. Fractions were collected every 2 minutes and those with
low amounts of peptide were pooled together (Fractions 8 to 11), producing 11 fractions for
subsequent LC-MS/MS analysis. An aliquot of 5% of the fraction volume was taken for total
proteome analysis while the remaining 95% was taken for phospho-enrichment.
TiO2-IMAC phospho enrichment. Phosphopeptide enrichment was carried out as
described in the TitansphereTmPhos-TiO2 Kit manual, using TiO2 resin (Titansphere, GL Sci-
ences Inc, Japan) in batch mode. The peptide fractions were resuspended in 80% ACN, 1M
Glycolic acid, 5% TFA and then mixed to the resin, previously equilibrated with the same solu-
tion. 1 mg of resin was employed for 500 μg of peptide. After the peptide-resin incubation for
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20 min at room temperature, the resin was washed three times with 80% ACN, 1% TFA.
Finally, the phosphopeptides were eluted with 0.5% NH4OH.
LC-MS/MS analysis. LC-MS/MS analysis was carried out using an UltiMate 3000
nanoRSLC UHPLC system (Thermo Scientific) coupled to a Q Exactive HF hybrid quadru-
pole-Orbitrap mass spectrometer (Thermo Scientific) (FingerPrints Proteomic Facility, Uni-
versity of Dundee, Scotland). Seven μL of proteome sample and 15 μL of phosphoproteome
sample were injected onto a PepMap nanoViper C18 trap column (100 μm x 2 cm, 5 μm, 100
Å, Thermo Scientific) at a flow rate of 5 μL/min. The trap column was equilibrated in 98%
Buffer A (2% ACN, 0.1% Formic acid (FA)) and then after sample injection washed for 10 min
with the same flow then moved in line with the C18 EasySpray resolving column (75 μm x 50
cm, PepMap RSLC C18, 2 μm, 100 Å). The peptides were eluted at a constant flow of 300 nL/
min with a linear gradient from 5 to 40% Buffer B (80% ACN/ 0.08% FA) over 120 min and
column was finally washed with Buffer B for 15 min and 98% Buffer A for 24 min. An ionspray
voltage of 1.95kV and a capillary temperature of 250˚C was applied to the EasySpray Column
via the EasySpray source. The total ms runtime was set at 156min. The Full MS parameters
were as follows: MS Resolution at 120,000; MS AGC target value at 3e6; maximum Ion Time at
50 msec and the mass range at 355-1800m/z. The data dependant MS/MS parameters were set
as follows: MS/MS resolution at 60,000; MS/MS AGC at 1e5; maximum Ion Time at 200 msec;
Loop count at 15; Isowidth at 1.2 m/z; fixed first mass at 100 m/z; Normalised Collision Energy
(NCE) at 32. The data dependent parameters were set as follows: min AGC at 2.4e3; Intensity
Threshold at 1.2e4; Charge exclusion at unassigned 1, 7, 8; Peptide Match as Preferred; Exclude
Isotope as On and Dynamic Exclusion at 45 sec. Based on these parameters the top 15 most
abundant ions were analysed per instrument duty cycle. Data was acquired with Xcalibur soft-
ware (Thermo Fisher Scientific).
Proteome and Phosphoproteome data analysis. The data processing was performed
with COMPASS (Coon OMSSA (Open Mass Spectrometry Search Algorithm) Proteomic Analy-
sis Software Suite [30] using DTA generation for data extraction from RAW files [31], and
searching against the T cruzi Esmeraldo annotated protein database from TriTrypDB release
9.0 containing 358,801 entries, using OMSSA 2.1.8. The mass tolerance was set to 20 ppm for
precursor ions and MS/MS tolerance was set to 0.8 Da. The enzyme was set to trypsin, allowing
up to 3 missed cleavages. NEM on cysteine and TMT sixplex on lysine was set as a fixed modi-
fication. Acetylation of protein N-termini, deamidation of asparagine and glutamine, oxida-
tion of methionine, pyro-glutamate and TMT sixplex on peptide N-termini were set as
variable modifications. For analysis of the phospho-proteomic data, phosphorylation of serine,
threonine and tyrosine were also set as variable modifications. Spectra were required to con-
tain four or more multi-isotope peaks with the charge state derived from the input file. The
false-discovery rate for protein and peptide level identification was set at 1%, using a target-
decoy based strategy. TMT reporter intensities, corrected for reporter impurities, for each pep-
tide were extracted using TagQuant 1.4 from within COMPASS. Protein groups were created
using Protein Hoarder 2.4.7.0, also within COMPASS, ensuring quantified proteins were iden-
tified by 2 or more unique peptides. For proteome results Purity Corrected Normalised (PCN)
values were used for fold change calculation (MTy/Ty). For phosphoproteome results, Purity
Corrected (PC) values were normalized by the median between the total amount of proteins
obtained from proteome data. PC manually normalized was used for phospho-fold change cal-
culation (MTy/Ty). Statistical analysis for validation of the results was performed by T Student
test (two-tail, 95%). Only peptides with ratio less than 0.8 or more than 1.2 (p-value less than
0.05) were considered.
In silico analysis of peptides and phosphopeptides. All the analysis on phosphopeptide,
phosphorylation sites, number of phospho-residues were performed using filters tools in the
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software Microsoft1Office Excell. The 303 phosphopeptides identified were used for kinase site
prediction by the software GPS 2.1: enhanced prediction of kinase-specific phosphorylation
sites, following the default parameters and high threshold. After kinase identification by the
software, only sequences with a score above 20 were selected. For analysis of conservation
between kinase family phospho-sites, all sequences obtained from GPS run were selected for
sequence logo building for each kinase family, using the software Weblogo (http://weblogo.
berkeley.edu/logo.cgi), following default parameters.
GO analysis. GO-terms enrichment analysis was performed by collecting the data infor-
mation from version 40 of the TriTrypDB: product description and Computed/curated GO
functions, Components and Process.
Metabolomic analysis
Intracellular metabolites. The pellets were extracted by addition of 500 μL cold metha-
nol:water (1:1, v/v) and lysed by sonication for 1 min at 30% frequency. Samples were centri-
fuged at 7,000 x g for 8 min. The supernatants were removed, from which 150 μL were
submitted to the GC-MS derivatization protocol and 200 μL were collected and pooled with all
other samples to obtain the quality control samples (QCs). A blank corresponds to the solvent
extractor at the same extraction conditions. Samples, blank solution and quality controls were
evaporated in a SpeedVac.
GC-MS derivatization. 10 μL of O-methoxyamine (15 mg/mL in pyridine) were added to
the samples, sonicated for 10 s and vortexed for 20 s. Samples were kept in the dark for 90 min
at room temperature. Ten μL of BSTFA + 1% TMCS (v/v) were added to the extracts, homoge-
nized and incubated for 30 min at 40˚C. After this step, 100 μL heptane containing 10 mg/mL
13C-methyl-ester (internal standard) were added and the extract homogenized.
GC-MS equipment. GC-MS analyses were performed in a gas chromatography equip-
ment (model 7890A, Agilent Technologies, CA, USA) coupled to a single quadrupole mass
spectrometer detector (model 5975C inert XL, Agilent Technologies). The separation was car-
ried out in a HP-5MS column (30 m length, 0.25 mm i.d., with 0.25 mm film composed of
95% dimethyl/ 5% diphenylpolysiloxane, Agilent Technologies). Helium was used as carrier
gas at 1.0 mL/min flow rate. The GC injector was maintained at 250˚C and samples were
injected with 1:10 split, 10 mL/min of He was used. The temperature gradient was: initial oven
temperature 60˚C for 1 min, increased to 300˚C at 10˚C/min, following by cooling to 60˚C in
1 min and maintained for 5 min. The run time was 25 min. The temperatures of the transfer
line of the detector, filament source, and the quadrupole were maintained at 290, 230 and
150˚C, respectively. The electron ionization source was -70 eV energy. The MS was operated
in scan mode in the range 50–600 m/z. The software Mass Hunter B.07.01 (Agilent Technolo-
gies) was used for operation and data acquisition.
Data treatment and multivariate analysis. Raw data files were converted into �.mzData
using the Qualitative Analysis Mass Hunter software B05.00 (Agilent Technologies). Previous
processing by the XCMS package (version 1.24.1) was performed followed by running at R
platform (3.1.0, R Foundation for Statistical Computing). The XCMS parameters were: fwhm
(full width at half maximum of model peak) = 4, snthresh (signal-to-noise cutoff) = 1.5, max
(maximum number of groups to identify in a single m/z slice) = 30, bw (bandwidth) = 2, and
mzwid (width of overlapping m/z slices) = 0.25. Other parameters were kept at default values.
After second grouping, fillPeaks was performed and the raw data was normalized by median
and the intensity of the internal standard. Metabolites identification was assisted by Fiehn RTL
Library (FiehnLib) and NIST MS, 2.0 g library (National Institute of Standards and Technol-
ogy mass spectra library) after peak deconvolution with AMDIS 2.69 (Automated Mass
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spectral Deconvolution and Identification System) software. Peaks were assigned with basis on
retention time (FiehnLib) and mass spectra fragmentation pattern (FiehnLib and NIST) after
retention index and retention time analysis. To consider the identification match factor and
NET factor should be greater than 700 and 85, respectively. Multivariate analyses PCA (Princi-
pal Component Analysis) and OPLS-DA (Orthogonal Partial Least Squares Discriminant
Analysis) performed in SIMCA P+ software (12.0.1 version, Umetrics, CA, USA) were used to
find differences between the studied groups. S-plot and Jack Knife from OPLS-DA were used
to find the discriminant metabolites and T-Student test using Prism Graphpad (version 7) was
applied to confirm the statistical significance (p-value < 0.05).
Immunofluorescence
Trypomastigotes (ECM-treated for 120 min or control) were fixed in 2% paraformaldehyde
for 15 minutes at room temperature, pelleted by centrifugation (4,000 x g for 5 minutes),
washed twice in PBS, resuspended in PBS, added to a coverslip and dried at room temperature.
After permeabilization of the parasites with PBS containing 1% BSA and 0.1% Triton X-100
for one hour at 37˚C, anti-phosphoserine, anti-phosphothreonine, anti-phosphotyrosine
(Invitrogen–dilution 1:200 for each antibody), anti-PAR monoclonal antibody (1:200) or anti–
TcHexokinase (kindly provided by Dr. Ana Ca´ceres, Universidad de Los Andes, Venezuela)
were added and incubated for 1 h at room temperature. After three washes with PBS contain-
ing 0.1% Triton X-100, the correspondent secondary antibodies were added (anti-rabbit or
anti-mouse-Alexa 555 conjugated (1: 5000); followed by one hour incubation at 37˚C. After
three washes in PBS-0.1%-Triton X-100, the coverslips were faced under a solution containing
50% glycerol, 50% milliQ H2O 2 mM sodium azide, and 20 μg/mL of 4’,6-diamidino-2-pheny-
lindole, dilactate (DAPI-Invitrogen). The images were taken on an ExiBlue™ camera (Qima-
ging1) coupled to a Nikon Eclipse E 600 optical microscope and deconvoluted using the
software Huygens Essential (Scientific Volume Imaging).
Enzyme activities
Frozen pellets of trypomastigotes (1 x 109 MTy or Ty) were resuspended in 1 mL of Lysis
Buffer (30 mM Tris-HCl, pH 7.6, 1 mM EDTA, 0.1% Triton e 0.25 M sucrose, containing
phosphatase and protease inhibitors, as described above, disrupted by ultrasonic for 4 x 10 s
(frequency of 40%, Thomas GEX 600 apparatus). After centrifugation (10 000 x g, 15 min), the
supernatant was separated and employed to measure the enzymatic activities (Hexokinase,
Pyruvate kinase and Lactate dehydrogenase). In all cases, the amount of NADH / NADPH was
measured spectrophotometrically at 340 nm and its concentration calculated (extinction coef-
ficient = 6.220 M-1 cm-1) [32]. Three independent biological samples were employed. Due to
the possible presence of ECM proteins in the MTy samples, the enzymatic activities were
expressed by 1x108 parasites. The number of parasites in each experimental point was also esti-
mated by a calibration curve using the amount of paraflagellar rod protein in the Western blot-
ting (anti-PAR monoclonal antibody 1:2000).
Hexokinase. Hexokinase activity was measured in the presence of a coupling system con-
taining glucose-6-phosphate dehydrogenase. Increase in NADPH concentration was followed
at 340 nm during 6 min at 30˚C. 10 μl of the extract (1.108 parasites) were incubated with the
reaction mixture containing 20 mM triethanolamine buffer pH 7.2, 200 mM D-glucose, 0.80
mM ATP, 8 mM MgCl2, 1 mM NADP and 5 U glucose-6-phosphate dehydrogenase
(Sigma1) [33]. As a control, the enzymatic activity was measured in the preparation incu-
bated at 56˚C for 1h. To measure HK activity in the extracts previously immunoprecipitated
with anti-Hexokinase antibodies, parasite extracts (2.108 parasites) were incubated under
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agitation with 3 μl of anti-Hexokinase antibodies and 50 μl of Protein A-Sepharose overnight
at 4˚C, washed extensively with PBS, treated or not with alkaline phosphatase as described
below. The HK activity was measured directly in the pellet, as described herein.
Pyruvate kinase. Pyruvate kinase activity was measured in the presence of a coupling sys-
tem containing lactate dehydrogenase for 6 min at 340 nm. Extracts of MTy or Ty were incu-
bated in a mixture containing 38 mM potassium phosphate, pH 7.6, 0.43 mM
phosphoenolpyruvate, 0.2 mM NADH (Sigma1), 6.7 mM MgSO4.7H2O (Sigma1), 1.3 mM
adenosine diphosphate (ADP), 20 U lactate dehydrogenase and 1 mM fructose 1,6-diphos-
phate [34].
Lactate dehydrogenase. Lactate dehydrogenase activity was measured at 340 nm for 5
min at 30˚C. Trypomastigotes extracts were incubated with the reaction mixture containing
50 mM potassium phosphate, pH 7.4, 0.2 mM NADH, 4 mM sodium pyruvate [32].
Alkaline phosphatase. Parasite extracts (3 x 108 MTy or Ty) were incubated with 5 U of
alkaline phosphatase (Boehringer Mannheim) for 1 h at 37˚C, followed by measurement of
hexokinase, pyruvate kinase or lactate dehydrogenase activities, as described above.
Results and discussion
Quantitative proteome and phosphoproteome of T. cruzi trypomastigotes
Previous studies demonstrated that there is a significant decrease in protein phosphorylation
upon parasite interaction with fibronectin or laminin, both components of the ECM. Thus we
decided to investigate possible changes in protein phosphorylation that could occur upon try-
pomastigote interaction with the entire ECM. The experiments outlined in the scheme (Fig
1A) were performed in order to analyze both the proteome and the phosphoproteome of the
parasites incubated with ECM.
The proteome and phosphoproteome analyses identified 3,093 proteins and 7,880 phospho-
peptides, respectively, with FDR values less than 1% and p scores less than e-7 for peptide iden-
tification (Fig 1B). Thirty six proteins (57%) and 212 phosphopeptides (67%) correspond to
proteins with unknown function (hypothetical proteins), as described by others in different
trypanosomes [27, 35–42], which is in accordance with the number of proteins (49.2%) with
unknown functions predicted by the genome sequence of T. cruzi [43] (Fig 1B). Sixty-three
non-unique proteins from the proteome data exhibited significant variations, with only 5
showing reduction and 58 showing an increase in their protein level (Fig 1B, S1 Fig, S1 Table).
Seventeen proteins showed changes where MTy/Ty�1.5, of which nine were hypothetical,
including the one with the greatest change (MTy/Ty�12.9). Among the proteins with
increased expression, it is worth emphasizing members of the gp85/trans-sialidase (TS) family,
involved in host cell infection by T. cruzi, (MTy/Ty = 2.2 for one member of group II and Mty/
Ty = 4.5 for one member of group IV); small GTP-binding protein rab6 (Mty/Ty = 3.8); ribo-
somal RNA processing protein 6 (MTy/Ty = 1.98; the splicing factor 3a; and the 2Fe-2S iron-
sulfur cluster binding domain containing protein (Mty/Ty = 1.77).
In the phosphoproteomic analysis, only phosphopeptides having MTy/Ty ratio below 0.8
or above 1.2, with p values less than 0.05, have been considered to evaluate the effect of ECM
on trypomastigote protein phosphorylation. Among the 303 phosphopeptides selected by
these criteria, 69 showed an increase and 234 a decrease in their phosphorylation levels. Of
these, 91 (33%) are proteins with known function, of which 19 showed an increase and 72 a
decrease in their phosphorylation levels (S2 Table; Fig 2A and 2B). Taken together the data
indicate that adhesion of trypomastigotes to ECM overall leads to protein dephosphorylation,
in agreement with previous observations with T. cruzi trypomastigotes incubated with ECM
components, fibronectin and laminin [27].
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Phosphorylation site analysis identified 371 differentially phosphorylated amino acid resi-
dues: 275 (74.1%) serine, 83 (22.4%) threonine and only 13 (3.5%) tyrosine residues, in accor-
dance with the abundance of serine/threonine kinases found in T. cruzi [44], the fact that T.
cruzi does not express receptor coupled tyrosine kinases but dual specificity kinases [44], as
well as with the phosphoproteome data described for different stages of the parasite [42, 45,
rev.46]. In silico analysis, as described below, suggested the involvement of different kinases
(CAMK, TKL, CMGC, CK1, AGC and others).
To understand better the role of the proteins controlled by phosphorylation during the par-
asite response to the ECM, GO-terms enrichment analysis was performed. Additional infor-
mation was obtained on the molecular function and/or sub-cellular localization of 29 proteins
and 126 phosphopeptides previously labeled as hypothetical (unknown function) based on ver-
sion 40 of the TriTrypDB. The data are shown in S1 Table and S2 Table. Most of proteins iden-
tified are related to structural function, pathogenicity, metabolism and protein
Fig 1. Protein and phosphoprotein changes in T. cruzi trypomastigotes following adhesion to ECM. (A) Schematic workflow of the experimental strategy to obtain
proteome, phosphoproteome (LC-MS/MS) and metabolite quantification (GC-MS). (B) Overview of the number of proteins and phosphopeptides identified after
LC-MS/MS.
https://doi.org/10.1371/journal.pntd.0007103.g001
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Fig 2. Phosphopeptides modified after trypomastigotes incubation with ECM for 120 min. (A) Heatmap with phosphopeptides (hypothetical and known proteins)
distribution according to the PCN (normalized) intensities. (B) Functional phosphopeptide distribution of known proteins (only phosphopeptides with p-value< 0.05
and ratio (MTy/Ty) lower than 0.8 or higher than 1.2 were considered). (C) Quantification of the phosphopeptides (PCN—normalized) from enzymes involved in
glucose metabolism. For proteins with more than one phosphosite, only the site with higher fold change (MTy/Ty) was shown, except for HK, for which the peptide with
T and S phosphorylation was shown. HK- Hexokinase, PPDK- pyruvate phosphate dikinase, PGM- phosphoglycerate mutase, PGK- phosphoglycerate kinase,
PFK1-phosphofructokinase 1, PFK2- phosphofructokinase 2, FRD- fumarate reductase, ADSL- adenylosuccinate lyase, ALT- alanine aminotransferase.
https://doi.org/10.1371/journal.pntd.0007103.g002
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phosphorylation. Both cytoplasm and axoneme seem to be the main localization of the identi-
fied phosphopeptides. Among the proteins identified, gp85/trans-sialidase (TS) family mem-
bers, involved in infection of host-cells by T. cruzi, were enhanced in trypomastigotes
incubated with ECM (MTy/Ty = 2.2 for one member of group II and MTy/Ty = 4.5 for one
member of group IV). Small GTP-binding protein rab6 (MTy/Ty = 3.8), ribosomal RNA pro-
cessing protein 6 (MTy/Ty = 1.98), splicing factor 3a and 2Fe-2S iron-sulfur cluster binding
domain containing protein (MTy/Ty = 1.77) were also identified in the group of the proteins
with an increased expression.
The following proteins are highly represented in the pool of proteins modified by phos-
phorylation (Fig 2B and S2 Table): proteins involved in metabolic processes (19 phosphopep-
tides); in phosphorylation/dephosphorylation (such as kinases and phosphatases, 20
phosphopeptides); structural proteins (such as flagellum and microtubule related proteins, 19
phosphopeptides); transport-associated proteins; and RNA/DNA binding elements. This sug-
gests an extensive metabolic adaptation occurring in trypomastigotes prior to host-cell
infection.
Of note, enzymes that participate in glucose metabolism, in addition to adenylosuccinate
lyase (ADSL) and alanine aminotransferase (ALT) (Table 1; Fig 2C), lipid metabolism (3-oxo-
5-alpha-steroid 4-dehydrogenase; putative (pseudogene) and ethanolamine phosphotransfer-
ase) (Fig 2B, S2 Table) are modified by phosphorylation.
Since a significant number of enzymes from the glucose metabolism were modified by
phosphorylation, their role was further investigated.
Phosphorylation of enzymes may regulate intermediate metabolism in
T. cruzi
Seven enzymes involved in carbohydrate metabolism were identified in the phosphoproteomic
analysis: hexokinase (HK); 6-phosphofructo-2-kinase/fructose-2;6 bisphosphatase (PFK2);
6-phospho-1-fructokinase (PFK1)(pseudogene); phosphoglucomutase (PGM); pyruvate phos-
phate dikinase (PPDK); phosphoglycerate kinase (PGK) and NADH-dependent fumarate
reductase (FRD), in addition to adenylosuccinate lyase and alanine aminotransferase (Fig 2C,
Fig 3, Table 1, S2 Table). Except for NADH-dependent fumarate reductase (MTy/Ty = 1.5)
and adenylosuccinate lyase (MTy/Ty = 2.2), all the others showed decrease in their phosphory-
lation levels when trypomastigotes were incubated with ECM (Table 1 and Fig 3). Most of
these enzymes are localized in the glycosomes, a peroxisome-like organelle essential for trypa-
nosomatids survival and characterized for containing most of the glycolytic/gluconeogenic
pathways in kinetoplastids, in addition to enzymes of other metabolic pathways, such as the
pentose phosphate pathway, beta-oxidation of fatty acids, and biosynthesis of pyrimidines
(rev. [47–49]). Likewise, phosphorylation of enzymes involved in carbohydrate metabolism
was described in the proteome and phosphoproteome of the glycosomes in T. brucei and Leish-
mania donovani [40, 41, 50].
Since the data suggested possible changes in the metabolism of T. cruzi, the metabolite con-
tent was analyzed by GC/MS to understand better the response of trypomastigotes upon adhe-
sion to ECM.
Metabolite quantification by GC-MS analysis suggests broader metabolic
changes in trypomastigotes incubated with ECM
GC-MS analysis allowed the identification of 21 metabolites with a significant variation
(p< 0.05) in the MTy/Ty ratio (S5 Table), from which significant changes were found for car-
bohydrate, lipid and amino acid metabolites. Some of these metabolites are substrates or
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products of the enzymes modified by phosphorylation that are found, although not exclusively,
inside the glycosomes (Fig 3A and 3B, Table 1). The following metabolites from the glycolytic
pathway were modified in parasites upon incubation with ECM: increase in glucose/galactose
(molecules indistinguishable in the GC-MS methodology) with ECM (MTy/Ty = 1.2); decrease
in pyruvic acid (MTy/Ty = 0.2) and lactic acid (MTy/Ty = 0.34). Interestingly, metabolites
derived from the glycolytic pathway branch and common to TCA cycle: succinic acid (MTy/
Ty = 1.37), malic acid (MTy/Ty = 1.21) and fumaric acid (MTy/Ty = 1.15), were increased in
parasites incubated with ECM. Succinate is considered the main source of reducing equiva-
lents to the respiratory chain through the action of a NADH-dependent fumarate reductase
and it is also (in addition to alanine) one of the main products excreted by trypanosomatids
[48, 51], although lactate excretion by T. cruzi [52] may increase, depending on metabolic
adaptations. These changes in metabolite level do not appear to correlate with changes in met-
abolic enzyme levels (S1 Table). Rather, they may reflect modulation of metabolic enzyme
activity. Although less representative in the metabolite quantification, an increase in free
amino acids in MTy (tyrosine, glycine or isoleucine, MTy/Ty ratio�1.4) and fatty acids
(mainly palmitic acid, MTy/Ty ratio�1.4) may also indicate wider changes in the metabolism
of MTy (S5 Table).
Phosphorylation level of hexokinase, pyruvate kinase and lactate
dehydrogenase-like may contribute to the control of glucose metabolism in
trypomastigotes incubated with ECM
To analyze the potential role of metabolic enzyme phosphorylation in modulating the glyco-
lytic pathway in MTy, enzymatic activities of hexokinase/glucokinase (HK/GK) and pyruvate
Fig 3. Metabolic enzymes modified by phosphorylation and metabolites quantification in trypomastigotes incubated with ECM. (A) Schematic representation of
enzymes from the glycolytic and glycolytic branch modified by phosphorylation (green) or dephosphorylation (red) and metabolites that increase (green) or decrease
(red) after trypomastigotes incubation with ECM for 120 min. (B) Relative abundance of metabolites in trypomastigotes (Ty) or trypomastigotes incubated with ECM
(MTy). The abundance of the metabolite was normalized by the median and internal standard. The metabolites (a) Glucose/galactose; (b) Pyruvate; (c) Lactate; (d)
Succinic acid; (e) Fumaric acid; f. Malic acid) are indicated in the graph. At least five distinct replicates were represented in each of the metabolite quantification.
Asterisks indicate the significance of the difference between MTy and Ty samples, according to T- Student Test with p< 0.05.
https://doi.org/10.1371/journal.pntd.0007103.g003
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kinase (PK) were determined, as well as for lactate dehydrogenase (LDH). Although PK and
LDH were not detected in our phosphoproteomic analysis (S2 Table), these enzymes were
included because significant depletion of pyruvate and lactate were observed in MTy (S5
Table). Further, as pointed out before, the changes in the metabolite levels seem to be indepen-
dent of the relevant metabolic enzyme expression levels accordingly to the proteomic data (S1
Table).
The enzymes HK and GK catalyze the formation of glucose-6-phosphate, the first reaction
of the glycolytic pathway and both lack the regulatory allosteric inhibition by glucose-6-phos-
phate, common to other organisms. Both are localized inside the glycosomes, of which HK
presents the highest activity [53, 54]. A distinct HK, which phosphorylates glucose and fruc-
tose, as well as GK activity were also described in the cytosol [53]. The affinity of HK for glu-
cose is higher than that of GK (Km values of 0.06 mM and 0.7 mM, respectively) in addition to
the higher amounts of HK over GK in the parasite [55]. However, in the present work we
could not separate the activities of both enzymes and, thus, they are collectively represented by
HK/GK activities.
The three phosphorylated residues of T. cruzi hexokinase (S161, T153, T159) (Table 2, S1
Table, S2 Fig) were located in the same peptide identified by LC-MS/MS and presented similar
changes in the phosphorylation level (MTy/Ty ratio = 0.76; 0.76 and 0.57, respectively). The
identified phosphorylated peptide is localized in the catalytic domain or in the substrate-bind-
ing site of the enzyme, according to the alignment of T. cruzi-HK (TcCLB.508951.20), T. brucei
(Tb927.10.2010) and the three isoforms of human-HK (P52790; P19367; P52789), performed
by ClustalW platform (S2B Fig). HK/GK activities from MTy and Ty homogenates were mea-
sured spectrophotometrically in the presence of a coupling system containing glucose-6-phos-
phate dehydrogenase. HK/GK activity is clearly reduced (by approximately 46%) in MTy
relative to Ty (Fig 4A,a). Previous treatment of Ty and MTy homogenates with alkaline phos-
phatase significantly reduced the activity (approximately 45% for Ty and 59% for MTy
extracts, Fig 4A,c,d). Also, the activity was drastically reduced (approximately 70%) when the
homogenate was previously treated at 56˚C for 1 h. Since HK is inhibited by small phosphate
molecules, such as PPi present in distinct organelles including glycosomes [53, 56, 57], the
experiment was repeated with the parasite extract previously immunoprecipitated with anti-
HK antibodies. Similar results have been obtained, confirming the relevance of phosphoryla-
tion for HK/GK activity (S4 Fig). Inhibition of the enzymatic activity by dephosphorylation is
consistent with the accumulation of glucose detected in MTy. However, one cannot rule out
other possibilities, such as changes in glucose transport in MTy, alterations of HK oligomeriza-
tion, which is usually tetrameric [54] or somehow by contributing to the hysteretic and coop-
erative behavior of HK at low enzyme concentration described in T. cruzi epimastigotes [58].
The phosphorylation of HK could be by auto-phosphorylation [59] or by protein kinase(s). Of
note, the same pattern of HK in MTy and Ty inside the glycosomes was shown by immunoflu-
orescence using specific anti-HK antibodies (S2A Fig). These data also indicate that no signifi-
cant changes in the number of glycosomes occur in MTy, in accordance with the literature,
where approximately the same number was found in the different forms of T. cruzi, in contrast
to the variability described during the life cycle of other species [60].
Pyruvate kinase (PK) was not detected in the phosphoproteome/proteome described
herein, as pointed out above, but the low amount of pyruvate found in MTy led us to measure
a corresponding enzymatic activity. In the cytosol, PK catalyzes the formation of pyruvate and
ATP from phosphoenolpyruvate and ADP and, in the case of T. cruzi epimastigotes, PK is
inhibited by millimolar concentrations of ATP and Pi and activated by micromolar concentra-
tions of fructose 2,6-bisphosphate (rev. [48, 61]) by the tetrameric stabilization of PK in
response to the effector binding [62].
Reprogramming of Trypanosoma cruzi metabolism by interaction with ECM
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007103 February 6, 2019 14 / 27
T
a
b
le
2
.
Id
en
ti
fi
ca
ti
o
n
o
f
k
in
a
se
s
a
n
d
p
h
o
sp
h
a
ta
se
s
m
o
d
if
ie
d
b
y
p
h
o
sp
h
o
ry
la
ti
o
n
a
ft
er
in
cu
b
a
ti
o
n
o
f
tr
y
p
o
m
a
st
ig
o
te
s
w
it
h
E
C
M
fo
r
1
2
0
m
in
.
C
o
m
p
le
te
in
fo
rm
at
io
n
is
sh
o
w
n
in
S
2
T
ab
le
.
P
h
o
sp
h
o
p
ep
ti
d
e
T
ri
T
ry
p
ID
P
ro
te
in
N
a
m
e
R
a
ti
o
M
T
y
/
T
y
p
-v
a
lu
e
P
h
o
sp
h
o
-
R
es
id
u
e
P
u
ta
ti
v
e
k
in
a
se
P
u
ta
ti
v
e
p
h
o
sp
h
o
-
p
ep
ti
d
e
K
in
a
se
S
co
re
iS
T
G
G
K
D
E
P
A
L
V
S
L
V
L
A
G
D
F
N
sD
A
G
S
P
P
IR
T
cC
L
B
.5
0
4
0
7
3
.1
0
en
d
o
n
u
cl
ea
se
/
ex
o
n
u
cl
ea
se
/
p
h
o
sp
h
at
as
e;
p
u
ta
ti
v
e
0
.7
7
9
4
7
8
8
0
8
0
.0
0
0
6
4
6
2
2
S
C
A
M
K
/
C
A
M
K
L
/
Q
IK
/S
IK
2
V
L
A
G
D
F
N
S
D
A
G
S
P
P
I
7
.5
1
4
k
L
S
P
S
E
P
N
V
A
y
IC
S
R
T
cC
L
B
.5
0
7
9
9
3
.8
0
g
ly
co
g
en
sy
n
th
as
e
k
in
as
e
3
;
p
u
ta
ti
v
e
0
.7
7
9
7
5
6
1
1
5
0
.0
4
2
3
3
8
1
1
Y
T
K
/T
ec
/
IT
K
P
S
E
P
N
V
A
Y
IC
S
R
�
�
�
2
.4
4
aF
V
P
L
IP
V
A
Q
N
A
N
P
T
P
E
S
P
F
L
L
sP
E
K
D
R
T
cC
L
B
.5
0
4
2
1
3
.9
0
in
o
si
to
l
p
o
ly
p
h
o
sp
h
at
e
k
in
as
e-
li
k
e
p
ro
te
in
;
p
u
ta
ti
v
e
0
.6
7
4
6
3
6
3
1
4
0
.0
3
4
5
0
7
2
3
S
A
G
C
/
G
R
K
/
B
A
R
K
/
B
A
R
K
1
P
E
S
P
F
L
L
S
P
E
K
D
R
�
�
5
.2
6
9
aF
V
P
L
IP
V
A
Q
N
A
N
P
T
P
E
S
P
F
L
L
sP
E
K
D
R
T
cC
L
B
.5
0
4
2
1
3
.9
0
in
o
si
to
l
p
o
ly
p
h
o
sp
h
at
e
k
in
as
e-
li
k
e
p
ro
te
in
;
p
u
ta
ti
v
e
0
.3
7
2
8
5
1
1
3
6
0
.0
0
6
7
0
6
2
3
S
A
G
C
/
G
R
K
/
B
A
R
K
/
B
A
R
K
1
P
E
S
P
F
L
L
S
P
E
K
D
R
�
�
5
.2
6
9
eD
T
Q
D
Q
N
K
tH
y
V
T
H
R
T
cC
L
B
.5
1
1
5
7
3
.4
0
m
it
o
g
en
-a
ct
iv
at
ed
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
5
2
5
4
9
7
0
2
0
.0
3
1
4
8
7
9
T
S
T
E
/
S
T
E
7
/
M
E
K
3
/
M
A
P
2
K
3
D
T
Q
D
Q
N
K
T
H
Y
V
T
H
R
�
4
.3
0
9
eD
T
Q
D
Q
N
K
tH
y
V
T
H
R
T
cC
L
B
.5
1
1
5
7
3
.4
0
m
it
o
g
en
-a
ct
iv
at
ed
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
5
2
5
4
9
7
0
2
0
.0
3
1
4
8
7
1
1
Y
T
K
/S
rc
/
S
R
M
/
P
T
K
6
Q
D
Q
N
K
T
H
Y
V
T
H
R
�
�
�
4
.1
7
7
n
T
F
E
L
T
N
G
T
P
T
IA
G
V
S
F
V
S
N
S
sP
T
G
G
A
P
S
F
F
R
T
cC
L
B
.5
1
0
1
0
5
.1
3
0
p
h
o
sp
h
at
id
y
li
n
o
si
to
l-
4
-p
h
o
sp
h
at
e
5
-k
in
as
e
ty
p
e
II
b
et
a;
p
u
ta
ti
v
e
0
.7
1
1
6
5
3
7
0
1
0
.0
0
1
7
1
8
2
2
S
O
th
er
/
P
L
K
/
S
A
K
/
P
L
K
4
V
S
F
V
S
N
S
S
P
T
G
G
A
P
S
4
.9
tF
tL
C
G
T
P
E
Y
L
A
P
E
V
IQ
S
R
T
cC
L
B
.5
0
9
8
0
5
.1
0
p
ro
te
in
k
in
as
e
A
ca
ta
ly
ti
c
su
b
u
n
it
;
p
u
ta
ti
v
e
1
.2
6
9
8
1
6
3
1
2
0
.0
3
8
1
7
3
3
T
O
th
er
/
C
A
M
K
K
/
M
et
a/
C
aM
K
K
2
�
�
�
�
�
T
F
T
L
C
G
T
P
E
Y
7
.8
2
2
tF
tL
C
G
T
P
E
Y
L
A
P
E
V
IQ
S
R
T
cC
L
B
.5
0
9
8
0
5
.1
0
p
ro
te
in
k
in
as
e
A
ca
ta
ly
ti
c
su
b
u
n
it
;
p
u
ta
ti
v
e
1
.2
6
9
8
1
6
3
1
2
0
.0
3
8
1
7
3
1
T
S
T
E
/
S
T
E
2
0
/
T
A
O
/
T
A
O
K
1
�
�
�
�
�
�
�
T
F
T
L
C
G
T
P
9
aA
E
V
S
V
G
E
sN
T
P
A
N
T
P
N
N
S
R
T
cC
L
B
.5
0
3
7
5
7
.4
0
p
ro
te
in
k
in
as
e
ck
2
re
g
u
la
to
ry
su
b
u
n
it
;
p
u
ta
ti
v
e
0
.7
5
8
4
8
2
2
6
9
0
.0
4
9
8
8
8
9
S
A
G
C
/
G
R
K
A
E
V
S
V
G
E
S
N
T
P
A
N
T
P
7
.9
9
1
q
A
G
V
G
N
P
P
P
L
S
P
L
Q
A
L
C
S
P
tA
T
G
L
S
P
V
L
L
G
E
K
G
D
H
H
L
P
V
S
K
T
cC
L
B
.5
0
9
2
3
1
.2
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
6
0
7
9
8
2
7
8
0
.0
4
0
9
8
2
0
T
C
M
G
C
/
D
Y
R
K
/
D
Y
R
K
1
/
D
Y
R
K
1
B
L
Q
A
L
C
S
P
T
A
T
G
L
S
P
V
7
.5
7
5
tT
V
A
S
A
A
T
A
V
A
S
V
T
sP
P
L
L
S
S
A
V
S
S
K
T
cC
L
B
.5
0
9
0
9
9
.1
5
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
8
4
0
3
6
8
5
8
0
.0
1
0
4
7
5
1
5
S
C
M
G
C
/
M
A
P
K
/
JN
K
/
JN
K
3
T
A
V
A
S
V
T
S
P
P
L
L
S
S
A
1
1
.0
4
2
rV
L
tP
S
G
G
F
D
D
T
Y
S
S
G
IE
L
F
D
E
IH
R
T
cC
L
B
.5
1
0
2
5
7
.1
3
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
6
4
8
8
3
2
0
2
0
.0
0
7
5
2
9
4
T
C
M
G
C
/
M
A
P
K
/
p
3
8
/
M
A
P
K
1
3
�
�
�
�
R
V
L
T
P
S
G
G
F
D
D
4
.7
0
6
(C
on
tin
ue
d)
Reprogramming of Trypanosoma cruzi metabolism by interaction with ECM
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007103 February 6, 2019 15 / 27
T
a
b
le
2
.
(C
o
n
ti
n
u
ed
)
P
h
o
sp
h
o
p
ep
ti
d
e
T
ri
T
ry
p
ID
P
ro
te
in
N
a
m
e
R
a
ti
o
M
T
y
/
T
y
p
-v
a
lu
e
P
h
o
sp
h
o
-
R
es
id
u
e
P
u
ta
ti
v
e
k
in
a
se
P
u
ta
ti
v
e
p
h
o
sp
h
o
-
p
ep
ti
d
e
K
in
a
se
S
co
re
iI
D
F
G
S
S
C
Y
L
T
D
N
L
S
sY
V
Q
S
R
T
cC
L
B
.5
0
6
8
6
9
.6
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
1
.4
6
8
2
9
1
8
4
4
0
.0
4
2
8
8
1
6
S
S
T
E
/
S
T
E
2
0
/
F
R
A
Y
/
O
S
R
1
Y
L
T
D
N
L
S
S
Y
V
Q
S
R
�
�
1
.3
0
7
iI
D
F
G
S
S
C
Y
L
T
D
N
L
sS
Y
V
Q
S
R
T
cC
L
B
.5
0
6
8
6
9
.6
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
1
.2
6
1
8
2
1
8
9
5
0
.0
4
4
0
9
7
1
5
S
S
T
E
/
S
T
E
7
/
M
E
K
3
/
M
A
P
2
K
4
C
Y
L
T
D
N
L
S
S
Y
V
Q
S
R
�
1
.3
2
5
tT
V
A
S
A
A
T
A
V
A
S
V
T
sP
P
L
L
S
S
A
V
S
S
K
T
cC
L
B
.5
0
9
0
9
9
.1
5
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
8
4
0
3
6
8
5
8
0
.0
1
0
4
7
5
1
T
T
K
L
/
M
L
K
/
M
L
K
/
Z
A
K
�
�
�
�
�
�
�
T
T
V
A
S
A
A
T
9
.2
5
iG
L
G
G
IG
T
F
T
S
S
sS
S
P
K
T
cC
L
B
.5
1
0
0
8
9
.1
3
0
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
0
0
0
9
0
6
9
0
.0
2
8
8
7
7
1
3
S
T
K
L
/
S
T
K
R
/
S
T
K
R
1
/
T
G
F
b
R
1
IG
T
F
T
S
S
S
S
S
P
K
�
�
�
5
.3
3
3
g
G
H
P
L
H
Q
E
N
Q
m
sE
E
D
E
D
V
E
A
L
P
H
S
V
S
Q
R
T
cC
L
B
.4
8
4
9
4
9
.9
se
ri
n
e/
th
re
o
n
in
e
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.6
2
9
3
3
5
5
2
5
0
.0
1
9
7
1
2
S
C
M
G
C
/
C
K
2
L
H
Q
E
N
Q
M
S
E
E
D
E
D
V
E
9
.8
9
4
tP
E
T
T
L
G
G
V
L
A
E
V
A
P
sL
IS
H
S
F
P
L
E
L
G
E
S
q
T
A
A
H
Q
E
L
H
P
D
L
G
R
T
cC
L
B
.4
8
4
9
4
9
.9
se
ri
n
e/
th
re
o
n
in
e
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
5
0
0
7
0
5
7
9
0
.0
2
9
8
0
1
1
T
C
M
G
C
/
M
A
P
K
/
p
3
8
/
M
A
P
K
1
3
�
�
�
�
�
�
�
T
P
E
T
T
L
G
G
4
.7
0
6
tP
E
T
T
L
G
G
V
L
A
E
V
A
P
sL
IS
H
S
F
P
L
E
L
G
E
S
q
T
A
A
H
Q
E
L
H
P
D
L
G
R
T
cC
L
B
.4
8
4
9
4
9
.9
se
ri
n
e/
th
re
o
n
in
e
p
ro
te
in
k
in
as
e;
p
u
ta
ti
v
e
0
.7
5
0
0
7
0
5
7
9
0
.0
2
9
8
0
1
1
6
S
O
th
er
/
N
E
K
/
N
E
K
9
/
N
E
K
9
V
L
A
E
V
A
P
S
L
IS
H
S
F
P
7
.9
8
3
lL
L
H
P
S
H
n
G
A
A
A
L
A
S
A
S
IE
sP
V
G
R
T
cC
L
B
.5
0
7
7
5
7
.5
0
se
ri
n
e/
th
re
o
n
in
e-
p
ro
te
in
p
h
o
sp
h
at
as
e
P
P
1
;
p
u
ta
ti
v
e
0
.6
5
3
0
5
9
3
3
0
.0
2
4
7
4
7
2
0
S
S
T
E
/
S
T
E
1
1
/
M
E
K
K
1
/
M
A
P
3
K
1
L
A
S
A
S
IE
S
P
V
G
R
�
�
�
3
.5
1
7
lL
L
H
P
S
H
N
G
A
A
A
L
A
sA
S
IE
S
P
V
G
R
T
cC
L
B
.5
0
7
7
5
7
.5
0
se
ri
n
e/
th
re
o
n
in
e-
p
ro
te
in
p
h
o
sp
h
at
as
e
P
P
1
;
p
u
ta
ti
v
e
0
.6
1
3
0
2
8
7
4
0
.0
1
7
7
1
1
1
5
S
S
T
E
/
S
T
E
2
0
/
K
H
S
/
H
P
K
1
N
G
A
A
A
L
A
S
A
S
IE
S
P
V
5
.6
8
3
�
T
h
e
as
te
ri
sk
s
in
d
ic
at
e
am
in
o
ac
id
s
n
o
t
p
re
d
ic
ta
b
le
b
y
th
e
G
P
S
3
.0
so
ft
w
ar
e
h
tt
p
s:
//
d
o
i.o
rg
/1
0
.1
3
7
1
/jo
u
rn
al
.p
n
td
.0
0
0
7
1
0
3
.t
0
0
2
Reprogramming of Trypanosoma cruzi metabolism by interaction with ECM
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007103 February 6, 2019 16 / 27
Reprogramming of Trypanosoma cruzi metabolism by interaction with ECM
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007103 February 6, 2019 17 / 27
As shown (Fig 4B,a), PK activity is strongly inhibited in trypomastigotes incubated with
ECM (approximately 65%). Treatment of the enzyme with alkaline phosphatase increased its
activity, mainly in MTy homogenates (25% Ty and 125% MTy), as shown in Fig 4B,c,d. The
decrease in pyruvate content observed could be attributed to the inhibition of pyruvate kinase
in the cytosol and/or pyruvate phosphate dikinase in the glycosome, which would lead to an
increase of dicarboxylic acids from the glycolytic branch (succinate, fumarate and malate) in
the glycosome, (cf. Fig 3 and S5 Table). However, higher consumption of pyruvate, for exam-
ple by its conversion to acetyl-CoA inside the mitochondria or to lactate in the cytosol, cannot
be ruled out.
Lactate dehydrogenase-like (LDH) activity was measured in the parasite homogenate due
to the decrease observed in lactate content in MTy (S5 Table). In many organisms, a tetrameric
form of the enzyme catalyzes the oxidation of lactate to pyruvate in the presence of NAD+ as
hydrogen acceptor. LDH activity in T. cruzi epimastigotes was attributed to the isoenzyme I of
@-hydroxyacid dehydrogenase localized inside the glycosomes and in the cytoplasm [63] and
to an unknown protein in T. brucei [51], since a typical lactate dehydrogenase is absent from
the genomes of trypanosomatids. The measurement of LDH activity showed approximately
33% reduction in MTy in comparison to trypomastigotes (Fig 4C,a), in agreement with the
decrease of lactate detected in MTy. LDH was also inhibited by alkaline phosphatase treatment
(approximately 65% for Ty and 41% for MTy extracts), reinforcing the role of phosphorylation
in modulating LDH activity (Fig 4C,c,d).
Alanine, rather than lactate, is usually the main product of the reduction of pyruvate in T.
cruzi, a reaction catalyzed by alanine aminotransferase inside the glycosomes (rev. [48, 49]).
Lactate excretion by the parasite [52] may increase depending on metabolic adaptations, as
described for the procyclic forms of T. brucei [51] and may explain the aforementioned results
in trypomastigotes. Although no significant differences in alanine content between MTy and
Ty were detected by GC/MS analysis, alanine aminotransferase is less phosphorylated in trypo-
mastigotes incubated with ECM and may be responsible for the switch to the LDH reaction for
NADH-reoxidation. Since T. cruzi possesses the enzyme repertoire for gluconeogenesis, this
pathway may also be activated in MTy, resulting in higher consumption of pyruvate, lactate
and glycerol, although no reserve polysaccharide was detected and gluconeogenesis has not
been fully established in T. cruzi.
Analysis of putative kinases involved in trypomastigote response to ECM
Our data suggest that incubation of trypomastigotes with ECM triggers metabolic adaptations
in the parasites, and that phosphorylation, or more specifically protein dephosphorylation,
may be involved in these processes. In spite of the relevance of the dephosphorylation and the
high representative number of phosphatases in the genome and proteome of T. cruzi [64, 42],
only two protein phosphatases with diminished phosphorylation levels in MTy were found: an
endonuclease/exonuclease/phosphatase responsible for dephosphorylation of DNA sequences
(TcCLB.504073.10) and PP1, a serine/threonine phosphatase (TcCLB.507757.50). Serine/
Fig 4. Enzymatic activity of three enzymes from the glucose metabolism: HK (A) PK (B) and LDH (C). (a)
Quantification of the respective enzyme activity in extracts of trypomastigotes of T. cruzi incubated (MTy) or not (Ty) with
ECM and expressed for 1 x 108 parasites. (b) Loading control of PAR (Paraflagellar-rod proteins) for the three replicates used
in the measure of each enzyme activity: HK (A), PK (B) and LHD (C). (c) Quantification of the enzyme activity of extracts
from trypomastigotes incubated (Ty_AP) or not (Ty) with alkaline phosphatase. (d) Relative quantification of enzyme
activity of extracts of trypomastigotes incubated with ECM followed by incubation (MTy_AP) or control (Ty) with alkaline
phosphatase and expressed as percentage of activity. The number of parasites (Fig 4a) was based on the calibration curve
presented in S3 Fig.
https://doi.org/10.1371/journal.pntd.0007103.g004
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threonine phosphatases are abundant in T. cruzi and constitute more than 50% of the 86 pro-
tein phosphatases in the genome. Protein phosphatase PP1 is dephosphorylated in MTy
(MTy/Ty = 0.65), which would be expected to increase its enzymatic activity and consequently
contribute to the dephosphorylation of proteins [65] (Table 2; S2 Table). Other protein phos-
phatases, such PP2A, PP2C or dual specific phosphatase were described in the proteome /
phosphoproteome of T. cruzi by different groups or in the glycosomes of T. brucei [41] or L.
mexicana [50], which might also contribute to the decrease of the phosphorylation level of the
proteins.
To understand further the signaling pathways activated in the parasite upon contact with
host ECM, the kinases capable of phosphorylate the peptides detected by LC-MS/MS were pre-
dicted by the GPS 2.1 software. Only the higher scores for each phospho-residue (S, T and Y)
in the peptide were selected, totaling 378 putative kinases for the 303 phosphopeptides identi-
fied by LC-MS/MS (S3 and S4 Tables). Most of the identified sites correspond to modifications
by serine/threonine kinases and the phosphorylation of tyrosine was attributed to the dual-
specificity kinases, in agreement with the absence of conventional tyrosine kinases in the
genome of trypanosomatids [44]. Of the 303 phosphopeptides analyzed, 78.5% and 21.1%,
respectively, presented one or two phosphorylated sites and only one phosphopeptide showed
three phosphorylated-sites (Fig 5A and 5B). The phosphorylated sites identified herein are pre-
dicted to be modified mainly by elements of the CMGC kinases superfamily (68), STE kinases
(62), TKL kinase (61), AGC kinase (31), CK1 family (31) (Fig 5D, Tables 1 and 2, S3 and S4
Tables). Kinases that do not belong to any characterized family are grouped as “Others”.
Only the catalytic subunit of protein kinase A, a member of the AGC kinase superfamily
showed in MTy a slightly increase in its phosphorylation level (MTy/Ty = 1.27). The phos-
phorylation of T197 of mouse PKA, located in the activation loop, which corresponds to T35
described herein for T. cruzi, increases PKA activity, indicating that upon interaction with
ECM, PKA is activated [66, 67]. Proteins responsible for a plethora of biological phenomena in
T. cruzi have been described as PKA substrates, such as kinases (type III PI3 kinase-Vps34, PI3
kinase, mitogen-activated extracellular signal-regulated kinase), cAMP-specific phosphodies-
terase (PDEC2), putative ATPase, DNA excision repair protein, aquaporin, hexokinase and
members of gp85/TS [68, 69]. The role of PKA during metacyclogenesis (differentiation of epi-
mastigotes to metacyclic trypomastigotes [70]) or during the amastigogenesis (differentiation
of trypomastigotes into amastigotes [42]) is well established, with the stimulation of adenylyl
cyclase and increment in cAMP concentration during the process. Albeit the relevance of PKA
in the physiology of the parasite, their specific role in trypomastigotes incubated with ECM
was not determined.
In contrast to PKA, reduction in phosphorylation was detected in the majority of the
kinases, for example in glycogen synthase kinase 3 (GSK3) and ERK1/2, presumably leading to
a decrease of their activities in MTy: Y187 from GSK3 (MTy/Ty = 0.78) corresponds to human
Y216 also located in the activation loop and whose phosphorylation is necessary for activity
[71]; T190 and Y192 from mitogen-activated protein kinase (MTy/Ty = 0.75), corresponds to
human T185/Y187, whose phosphorylation is necessary for ERK1/2 activation [72]. Dephos-
phorylation of ERK1/ 2 was also observed in the incubation of trypomastigotes with laminin
or fibronectin [27].
Decrease in phosphorylation of other kinases was also found: protein kinase ck2 regulatory
subunit (MTy/Ty = 0.76), inositol-related signaling kinases; inositol polyphosphate kinase-like
protein (MTy/Ty = 0.67) and phosphatidylinositol-4-phosphate 5-kinase type II beta (MTy/
Ty = 0.37) (Table 2). Whether this is a reflection of their activation status remains to be
determined.
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Fig 5. Conservation of the phosphorylation sites among the modified phosphopeptides in trypomastigotes incubated with ECM and characterization of the
putative kinases involved in the phosphorylation events. (A) Number of amino acid residues (S, T and Y) modified by phosphorylation (green) or dephosphorylation
(red) in ECM-treated trypomastigotes. (B) Number of phosphorylated amino acids residues for each phosphopeptide. (C) Sequence logo of the peptides identified by the
software GPS 2.1 distributed according to the kinase family. (D) Identification and quantification of putative kinases responsible for phosphorylation of the
phosphopeptides modified after parasite-ECM incubation. Only phosphosites with higher score were selected. The prediction was made using the software GPS 2.1:
enhanced prediction of kinase-specific phosphorylation sites. The arrow indicates the kinase family able to phosphorylate the majority of peptides of the
phosphoproteome.
https://doi.org/10.1371/journal.pntd.0007103.g005
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The phosphopeptides assigned to particular kinase families by the GPS 2.1 software (Fig
3D) were used for the construction of sequence logos, which correspond to sequence align-
ment with the central point as the likely phospho-amino acid residue (Fig 3C). For the
AGC kinase families, "other" and CK1, no consensus was observed in the amino acid
sequences surrounding the S/T residue. For the "Atypical", TK and STE families some
amino acids were identified with a high level of conservation. The analysis of the sequence
logos (Fig 3C) indicates some conservation relative to the sites already characterized for
humans, such as the group of peptides phosphorylated by CMGC, where a proline next to
the phosphorylation site was also identified; lysine and arginine near the phosphorylation
site for AGC; residues of aspartate and glutamate for CK1 family substrates and the conser-
vation of phenylalanine and proline residues near the phosphorylated site for the atypical
kinases.
Concluding remarks
Incubation of T. cruzi trypomastigotes with the extracellular matrix results in important and
more extensive changes than the ones previously described by the incubation of trypomasti-
gotes with fibronectin or laminin [27]. Reduction in the phosphorylation level of proteins
seems to be a general event in trypomastigotes incubated with ECM (Tables 1 and 2, S2 Table).
Kinases, except for PKA, PP1 phosphatase and enzymes from the glycolytic pathway and prob-
ably the glycolytic branch exemplify these decreases (S2 and S3 Tables). Strikingly, correlating
with the observed decrease in phosphorylation level of the enzymes, a significant inhibition of
hexokinase, pyruvate kinase and lactate dehydrogenase-like were detected. (S2 and S5 Tables,
Fig 4). These results, in association to the slightly increase of glucose and drastic reduction of
pyruvate and lactate strongly suggest that ECM triggers important reduction in the glycolytic
pathway in T. cruzi trypomastigotes. Although hexokinase is among the many substrates
described for PKA [69], a possible correlation between these enzymes has not been explored
herein. Interestingly, trans-sialidases, surface glycoproteins belonging to the T. cruzi gp85/
trans-sialidase family, are also one of the substrates for PKA [69] and PKA activity and trans-
sialidase expression has been associated with differentiation and invasion of host cells by T.
cruzi [73]. A similar coincidence of increase in PKA activity and expression of two members of
the gp85/trans-sialidase family were observed upon incubation of trypomastigotes with ECM
(MTy/Ty = 2.2 and 4.5, S1 Table), perhaps preparing the parasites for an efficient invasion of
the host cell. The possibility that members of the large gp85/ trans-sialidase family interact
with different components of ECM to trigger all the modifications described here remains to
be determined.
Taken together, the data presented herein suggest reprogramming of the metabolism of try-
pomastigotes triggered by their interaction with the extracellular matrix, an obligatory step
before cell invasion and differentiation into amastigotes, the multiplicative stage of T. cruzi in
the vertebrate host. The reduction in glycolytic enzyme activity in trypomastigotes by phos-
phorylation/dephosphorylation events seems to be part of this reprogramming, with the
involvement of yet to be identified protein kinases and phosphatases.
Supporting information
S1 Fig. Proteome and phosphoproteome profile. A. Volcano plot of total protein identified
after LC-MS/MS. The Y-axis represents the -log 2 p-value (T-test) and X-axis represents the
-log 2 Ratio of Protein intensity MTy/Ty. B. Volcano plot of total phosphopeptides identified
after phospho-enrichment followed by LC-MS/MS. Y and X-axis are the same as represented
in A. C. Heat map of the 64 proteins with significant differences between MTy and Ty samples.
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The Tritryp ID for each protein identified is indicated on the right.
(TIF)
S2 Fig. HK characterization in trypomastigotes incubated (MTy) or not (Ty) with ECM.
(A) Sub-cellular localization of Hexokinase (red), PFR (green) and nuclei (blue) in trypomasti-
gotes. (B) Sequence aligment between isoforms of human-HKs (P52790; P19367; P52789) and
Tc-HK (Q4D3P5/TcCLB.508951.20). The arrows indicate the phospho-residues and orange
box indicates the phosphopeptide identified after phosphoproteome analysis.
(TIF)
S3 Fig. Correlation between the number of trypomastigotes and PFR loading for Ty and
MTy extracts used for HK (A), PK (B) and LDH (C) enzymatic quantification assays. (a)
Immunoblotting of 20 x105 to 1.2 x 105 trypomastigotes extracts with antibody anti-Parafla-
gellar rod proteins (PFR). (b) Curve of linear correlation between curve area of the immuno-
blotting bands (a) and trypomastigote numbers. (c) Estimative of parasite number for each
extract employed for enzymatic quantification assay shown in Fig 4 and S4 Fig.
(TIFF)
S4 Fig. Hexokinase activity in Ty and MTy extracts immunoprecipitated with anti-Hexoki-
nase antibodies (HK IP) and treated with alkaline phosphatase (AP). Extracts from para-
sites previously incubated with ECM for 2h (TyM2h) or with medium (Ty2hC, control) were
immunoprecipitated with anti-HK antibodies (TyMHK IP and Ty2hC+), treated (+AP) or not
with AP, followed by the measurement of HK activity. C- Ty extract. The number of parasites
was based on the calibration curve presented in S Fig 3.
(TIFF)
S1 Table. Proteome overview. Proteins identified with significative difference between Ty
and MTy (T-Student Test, p< 0.05 for TMT normalized quantification (PCN)). p-Scores rep-
resent the confidence of protein identification by the software. Only proteins with p-score< e-
7 were selected.
(XLSX)
S2 Table. Phosphoproteome overview. Phosphopeptides identified with significant differ-
ences between Ty and MTy extracts (T-Student Test, p< 0.05 for TMT normalized quantifica-
tion (PCN manual values)). p-Scores represent the confidence of protein identification by the
software. Only p-score < e-7. Residues of S, R and Y represented in lower case correspond to
the phosphorylation sites.
(XLSX)
S3 Table. Phosphoproteome and identification of putative kinases using the GPS analysis.
Phosphopeptides identified with significant differences between Ty and MTy extracts (T-Stu-
dent Test, p< 0.05 for TMT normalized quantification (PCN manual values)). Putative kinase
family able to phosphorylate each one of the substrates and the peptide sequence surrounding
the phosphorylation site, are represented in the Table. The score calculated by GPS algorithm
evaluates the potential of the phosphorylation.
(XLS)
S4 Table. Phosphoproteome and identification of only one putative kinase (upper score,
after GPS analysis) for each phosphopeptide substrate. Phosphopeptides identified with sig-
nificant differences between Ty and MTy extracts (T-Student Test, p< 0.05 for TMT normal-
ized quantification (PCN manual values)). The putative kinase family able to phosphorylate
each substrate and the peptide sequence surrounding the phosphorylation site are represented.
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Only the upper score calculated by GPS algorithm for each phosphopeptide was selected.
(XLSX)
S5 Table. Quantification of metabolites in trypomastigotes incubated (MTy) or not (Ty)
with ECM for 120 min.
(XLSX)
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